Mankind Pharma Completes NCD Redemption and Interest Payments
Mankind Pharma Ltd · Others (Uncategorized) · 16 Oct 2026, 10:34 pm
Mankind Pharma Completes NCD Redemption and Interest Payments Mankind Pharma paid half-yearly interest and fully redeemed its matured NCDs on 16th Oct'26. The company completed the full redemption of 125,000 NCDs (ISIN: INE634S07025) worth ₹1,250 crore upon maturity, leaving zero outstanding amount for the tranche. It disbursed gross interest of ₹50.07 crore (net ₹49.97 crore) for ISIN INE634S07025 and gross interest of ₹99.90 crore (net ₹99.86 crore) on its ₹2,500 crore issue (ISIN: INE634S07033). All payments were executed on schedule.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA · 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference · 06 Nov 2026
- Please find attached intimation regarding ESG Rating · 05 Nov 2026
- Intimation of participation in the Investor Conference. · 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 · 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL · 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet · 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 · 27 Oct 2026
